Interactive science lab
Five calculators: extraction, creaming, freeze-drying, stability, resolution.
Calculators, datasets and methods articles, grouped by discipline. Labels separate published measurements and regulations from proposals and simulations.
Status. EUTECNIQ Sciences is a company in formation. It has no laboratory, no measured results and no customers yet.
| Page | Labels | Verified data | Peer-reviewed | Regulation or guidance | Third-party estimate | Proposal, partner or risk | Simulation or schematic |
|---|---|---|---|---|---|---|---|
| Interactive science lab | 10 | 1 (10%) | 1 (10%) | 0 (0%) | 0 (0%) | 0 (0%) | 8 (80%) |
| Thermodynamics & COSMO-SAC | 28 | 10 (36%) | 4 (14%) | 0 (0%) | 0 (0%) | 0 (0%) | 14 (50%) |
| Quantum chemistry | 24 | 3 (12%) | 4 (17%) | 0 (0%) | 0 (0%) | 3 (12%) | 14 (58%) |
| Ab initio reactivity | 21 | 0 (0%) | 5 (24%) | 0 (0%) | 0 (0%) | 2 (10%) | 14 (67%) |
| Design space & optimization | 18 | 0 (0%) | 6 (33%) | 0 (0%) | 0 (0%) | 2 (11%) | 10 (56%) |
| Large Botanical Model | 33 | 8 (24%) | 6 (18%) | 0 (0%) | 0 (0%) | 13 (39%) | 6 (18%) |
| Botanical Intelligence | 21 | 4 (19%) | 2 (10%) | 0 (0%) | 0 (0%) | 11 (52%) | 4 (19%) |
| Evidence & pharmacokinetics | 21 | 1 (5%) | 10 (48%) | 3 (14%) | 1 (5%) | 4 (19%) | 2 (10%) |
| Combination science & synergy | 11 | 1 (9%) | 5 (45%) | 0 (0%) | 0 (0%) | 1 (9%) | 4 (36%) |
| Lessons learned | 13 | 7 (54%) | 4 (31%) | 1 (8%) | 0 (0%) | 0 (0%) | 1 (8%) |
| Operational excellence | 30 | 10 (33%) | 5 (17%) | 0 (0%) | 0 (0%) | 0 (0%) | 15 (50%) |
| Sustainability and LCA | 17 | 5 (29%) | 5 (29%) | 4 (24%) | 2 (12%) | 0 (0%) | 1 (6%) |
| Market data | 25 | 9 (36%) | 1 (4%) | 0 (0%) | 14 (56%) | 0 (0%) | 1 (4%) |
| Competitive landscape | 21 | 13 (62%) | 0 (0%) | 1 (5%) | 0 (0%) | 7 (33%) | 0 (0%) |
| Global botanical atlas | 17 | 6 (35%) | 4 (24%) | 1 (6%) | 1 (6%) | 5 (29%) | 0 (0%) |
| Global trade data | 18 | 13 (72%) | 2 (11%) | 0 (0%) | 0 (0%) | 3 (17%) | 0 (0%) |
| Model register | 2 | 1 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (50%) |
| Sources & methodology | 13 | 2 (15%) | 2 (15%) | 3 (23%) | 1 (8%) | 4 (31%) | 1 (8%) |
There is no label for verified EUTECNIQ experimental results because none exist yet.
| Label | Meaning | How to read it |
|---|---|---|
| Verified fact | Verified fact or government data from a primary source | Checked against the original record (for example NIST, FDA, UN Comtrade); dated where it can change. |
| Peer-reviewed | Established published evidence | Comes from a peer-reviewed paper or standard reference work; cited with its DOI. |
| Regulatory requirement | Statute or regulation | Binding text, such as the FD&C Act or 21 CFR, cited to the section and dated. |
| Agency guidance | FDA or other agency guidance | A non-binding recommendation; marked final or draft, with its date. |
| Third-party estimate | Market research and other estimates | Someone else's estimate, reported with its definitions and scope; not verified by EUTECNIQ. |
| Founder-reported | The founder's prior experience | A result achieved at a prior employer and reported by the founder; it belongs to that employer, not to EUTECNIQ. |
| Proposal | Management proposal or plan | Something EUTECNIQ would do; it has not been built or done. |
| Simulation | Educational simulation or illustrative model output | Calculated from published equations with example inputs; not a measurement. |
| External partner | Performed by a qualified external partner | Work a contract laboratory or other partner would carry out under agreement. |
| Risk | Risk | A known way a plan or result could fail, stated next to the claim it qualifies. |
One chart never mixes categories without labeling each one. The six kinds in the heat map fold the ten labels: proposals, external-partner work, founder-reported experience and risks form one kind; regulation and agency guidance form another.
| Topic (page) | 2000 | 2005 | 2010 | 2015 | 2020 | 2024 | 2025 | CAGR 2015–2025 | Search terms in title or abstract |
|---|---|---|---|---|---|---|---|---|---|
| Solvent thermodynamics models (COSMO-RS, UNIFAC, NRTL) | 0 | 6 | 10 | 26 | 32 | 69 | 83 | 12.3% | ("COSMO-RS" OR "COSMO-SAC" OR UNIFAC OR NRTL) AND (solubility OR extraction OR solvent OR solvents) |
| DFT studies of plant phenolics | 0 | 15 | 30 | 69 | 118 | 182 | 253 | 13.9% | ("density functional theory" OR DFT) AND (flavonoid OR flavonoids OR polyphenol OR polyphenols OR phenolic OR "natural product" OR "natural products") |
| Bond dissociation enthalpy of antioxidants | 1 | 3 | 10 | 6 | 9 | 14 | 20 | 12.8% | ("bond dissociation enthalpy" OR "bond dissociation energy") AND (phenolic OR phenol OR antioxidant OR antioxidants OR flavonoid OR flavonoids) |
| Response-surface optimization of extraction | 10 | 13 | 69 | 264 | 387 | 526 | 592 | 8.4% | ("response surface methodology" OR "Box-Behnken" OR "central composite design" OR "design of experiments") AND extraction |
| Deep learning on natural-product chemistry | 0 | 0 | 0 | 0 | 9 | 37 | 65 | from zero | ("deep learning" OR "large language model" OR "foundation model" OR transformer) AND ("natural product" OR "natural products" OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") |
| Bayesian optimization and active learning | 5 | 9 | 26 | 39 | 109 | 274 | 311 | 23.1% | ("Bayesian optimization" OR "Bayesian optimisation" OR "active learning") AND (extraction OR formulation OR chemistry OR process) |
| Pharmacokinetics of botanicals | 11 | 43 | 55 | 124 | 184 | 315 | 477 | 14.4% | (pharmacokinetics OR pharmacokinetic) AND ("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") |
| Synergy and herb-drug interactions | 17 | 43 | 64 | 140 | 259 | 387 | 677 | 17.1% | (synergy OR synergistic OR "herb-drug interaction" OR "herb-drug interactions") AND ("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") |
| Adulteration and liver injury from supplements | 4 | 10 | 38 | 66 | 105 | 128 | 107 | 5.0% | (adulteration OR adulterated OR "liver injury" OR hepatotoxicity) AND ("dietary supplement" OR "dietary supplements" OR "herbal supplement" OR "herbal supplements" OR "herbal medicine") |
| Six Sigma, lean and SPC in manufacturing | 3 | 9 | 11 | 14 | 14 | 19 | 26 | 6.4% | ("six sigma" OR "lean manufacturing" OR "statistical process control" OR "process capability") AND (pharmaceutical OR food OR manufacturing) |
| Life-cycle assessment of extraction | 0 | 3 | 13 | 16 | 29 | 73 | 83 | 17.9% | ("life cycle assessment" OR "life-cycle assessment" OR LCA) AND (extraction OR "plant extract" OR botanical OR biorefinery) |
| Ethnobotany of medicinal plants | 9 | 17 | 28 | 108 | 104 | 97 | 109 | 0.1% | ("medicinal plant" OR "medicinal plants") AND (ethnobotany OR ethnobotanical) |
| Trade and supply of medicinal plants | 2 | 4 | 10 | 23 | 22 | 46 | 51 | 8.3% | ("medicinal plant" OR "medicinal plants" OR "herbal medicine" OR "herbal products") AND (trade OR "supply chain" OR harvesting OR "wild collection") |
Five calculators: extraction, creaming, freeze-drying, stability, resolution.
Phase diagrams, COSMO-RS and UNIFAC against measured data.
DFT surface charges and COSMO-SAC solvent screening.
Computed O–H bond strengths of plant phenolics.
A published extraction model in 3D, with Pareto fronts.
A proposed multimodal model; none exists yet.
Hybrid models defined before any data exist.
Evidence ladder, bioavailability and herb–drug interactions.
Documented interactions, and what proving synergy takes.
Documented failures and the controls each prompted.
SPC, capability, FMEA and FDA inspection data.
Life-cycle assessment, solvent greenness, wild harvest.
Sales, growth rates and publisher estimates, sourced.
Named companies, from their own filings.
Regional botanicals on a world map, with status.
Customs data on botanical raw materials.
Every calculator: equations, limits, verification.
Every reference, dated and searchable.
Research partners are welcome to ask about the models and sources behind any page.